Ginkgo Bioworks (DNA) Stock: Why The Price Jumped Up Today

By Amit Chowdhry ● Mar 29, 2022
  • The stock price of Ginkgo Bioworks (NYSE: DNA) increased by over 12% during intraday trading today. This is why.

The stock price of Ginkgo Bioworks (NYSE: DNA) increased by over 12% during intraday trading today. Investors are responding positively to the company’s fourth-quarter results.

Ginkgo Bioworks had reported a Q4 EPS of ($1.10), which was $1.06 less than the analyst estimates of ($0.04). The revenue for the quarter was $148.5 million compared to the consensus estimate of $94.81 million. 

Going forward, Ginkgo Bioworks expects FY2022 revenue of $325-$340 million, compared to the consensus of $305.8 million.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.